“Examining the Therapeutic Potential of CRISPR-Cas9 Gene Editing in Spondyloarthritis: Efficacy of TNF Inhibitor Adalimumab: Research Article”. International Journal of Research in Medical and Clinical Science 2, no. 02 (July 1, 2024): 20–30. Accessed October 21, 2026. https://www.journalserapublications.com/index.php/ijrmcs/article/view/7.